XML 17 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 351,185 $ 551,801
Accounts receivable 206,442 7,727
Inventory 146,362 85,714
Prepaid assets 38,820 36,350
Restricted cash 1,114 1,273
Other current assets 22,408 36,658
Total current assets 766,331 719,523
Non-current assets:    
Right-of-use assets 16,745 18,747
Property and equipment, net 4,345 6,148
Other assets 1,309 15,799
Total assets 788,730 760,217
Current liabilities:    
Accounts payable 37,516 37,342
Accrued expenses 127,806 95,139
Current portion of development liability 75,830 29,504
Current portion of right-of-use liabilities 6,441 5,625
Total current liabilities 247,593 167,610
Long-term liabilities:    
Long-term development liability 239,817 315,647
Convertible senior notes 93,033 92,736
Right-of-use liabilities 11,454 14,352
Other liabilities 2,312  
Total liabilities 594,209 590,345
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 10,000 shares authorized and zero shares issued and outstanding at December 31, 2023 and 2022 0 0
Common stock, $0.0001 par value; 200,000 shares authorized at December 31, 2023 and 2022; 119,556 and 110,772 shares issued and outstanding at December 31, 2023 and 2022, respectively 12 11
Additional paid-in capital 3,035,539 2,479,596
Accumulated other comprehensive loss (3,542) (875)
Accumulated deficit (2,837,488) (2,308,860)
Total stockholders’ equity 194,521 169,872
Total liabilities and stockholders’ equity $ 788,730 $ 760,217